Experiment 370400

Worktypes

PHARMACOLOGY OF COMPOUND - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBED

Compounds isolated

GIBBERELLIN A-20GIBBERELLIN A-30

Alerts

BIOLOGICAL ACTIVITY REPORTED HAS BEEN PATENTED.A MIXTURE OF PURE COMPOUNDS WAS USED TO OBTAIN THE REPORTED EFFECT.DATA INCOMPLETE - DERIVED FROM AN ABSTRACT.

Details

PropertyValue
Pharmacology
BENIGN PROSTATIC HYPERPLASIA IMPROVEMENT
Administration routeINTRAGASTRIC
OrganismEmpty organism
CitationODEN,P:. (1992). USE OF GIBBERELLINS FOR THE TREATMENT OF PROSTATITIS.. ()
Amount utilized
Compound isolated
Dose amount50.0 MG
Number2
Qualitative resultACTIVE
AnimalRAT
Per unitANIMAL
Dose expressionDOSE
GenderMALE